Research Article| Volume 38, ISSUE 4, P465-475, October 1988

Estradiol plasma levels during long-term treatment with norplantR subdekmal implants

      This paper is only available as a PDF. To read, Please Download here.


      Estradiol (E2) plasma levels were assessed in forty-seven women treated for one through seven years with the same set of NorplantR implants. Each woman was subjected to one (n = 34), two (n = 11) or three (n = 2) sampling runs. At each sampling run, blood samples were drawn every third or fourth day during 5 or 6 consecutive weeks. Sampling runs were classified as ovulatory (n = 11), anovulatory (n = 49) or uncertain (n = 1) according to progesterone levels. Controls were Copper T users (n = 8), all classified as ovulatory.
      No significant differences were found for the mean E2 levels between NorplantR users and Copper T users and between ovulatory and anovulatory cases. The mean of the peak E2 value found in each sampling run was significantly higher in anovulatory NorplantR subjects than in the control group. The mean of the minimum E2 level observed was significantly lower in NorplantR cases than in Copper T users. A single woman from the NorplantR group and none from the Copper T group had all E2 values below 370 pmol/l.
      The inhibition of the reproductive function induced by NorplantR implants is associated with a wider range of E2 circulating levels. None of the values observed at the extremes should cause serious concerns. High peaks are transitory and opposed by the antiestrogenic effect of levonorgestreJ. Persistent low levels which could be associated with a hypoestrogenic state were observed in a single case.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • World Health Organization
        Facts about an implantable contraceptive: Memorandum from a WHO meeting. Bulletin of the World Health Organization. 63. 1985: 485-494
        • Weiner E.
        • Johansson E.D.B.
        • Wide L.
        Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel.
        Contraception. 1976; 13: 287-298
        • Weiner E.
        • Johansson E.D.B.
        Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.
        Contraception. 1976; 14: 81-92
        • Moore D.E.
        • Roy S.
        • Stanczyk F.Z.
        • Mishell Jr., D.R.
        Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
        Contraception. 1978; 17: 315-328
        • Croxatto H.B.
        • Dlaz S.
        • Pavez M.
        • Miranda P.
        • Brandeis A.
        Plasma progesterone levels during long-terra treatment with levonorgestrel silastic implants.
        Acta Endocrinologica. 1982; 101: 307-311
        • Croxatto H.D.
        • Díaz S.
        • Pavez M.
        • Croxatto H.B.
        Histopathology of the endometrium during continuous use of levonorgestrel.
        in: Zatuchni G.I. Goldsmith A. Shelton J.D. Sciarra J.J. Long-Acting Contraceptive Delivery Systems. Harper & Row, Publishers, Philadelphia1984: 290-295
        • Shaaban M.M.
        • El-Nashar I.M.
        • Ghaneimah S.A.
        • Gomaa A.A.
        • Salah M.
        • Abdel-Aleem A.M.
        Hormonal changes during the first year of use of subdermal levonorgestrel implants, NorplantR.
        Contraception. 1984; 30: 391-405
        • Brache V.
        • Fafindes A.
        • Johansson E.
        • Alvarez F.
        Anovulation, Inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of NorplantR implants.
        Contraception. 1985; 31: 261-272
        • Alvarez F.
        • Brache V.
        • Tejeda A.S.
        • Faúndes A.
        Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term NorplantR use.
        Contraception. 1986; 33: 111-119
        • Croxatto H.B.
        • Díaz S.
        • Salvatierra A.M.
        • Morales P.
        • Ebensperger C.
        • Brandeis A.
        Treatment with NorplantR subdermal implants inhibits sperm penetration through cervical mucus in vitro.
        Contraception. 1987; 36: 193-201
        • Croxatto H.B.
        • Díaz S.
        • Miranda P.
        • Elamsson K.
        • Johansson E.D.B.
        Plasma levels of levonorgestrel in women during long-term use of NorplantR.
        Contraception. 1981; 23: 197-209
        • Díaz S.
        • Pavez M.
        • Miranda P.
        • Robertson D.M.
        • Sivin I.
        • Croxatto H.B.
        A five-year clinical trial of levonorgestrel silastic implants (NorplantR).
        Contraception. 1982; 25: 447-456
        • Díaz S.
        • Pavez M.
        • Miranda P.
        • Johansson E.D.B.
        • Croxatto H.B.
        Long-term follow-up of women treated with NorplantR implants.
        Contraception. 1987; 35: 551-567
        • Díaz S.
        • Pavez M.
        • Cárdenas H.
        • Croxatto H.B.
        Recovery of fertility and outcome of planned pregnancies after the removal of NorplantR subdermal implants or Copper-T lUDs.
        Contraception. 1987; 35: 569-579
        • Rasanen T.
        • Nilsson C-G.
        • Ylostalo P.
        • Widholm O.
        Presented at the 12th World Congress on Fertility and Sterility, SingaporePreliminary report of ovarian ultrasonography findings during NorplantR and levonorgestrel-releasing IUD contraceptive treatment. October, 1986
        • Odlind V.
        • Olsson S-E.
        • Lindgren P.G.
        Studies of ovulation using ultrasonography in women with NorplantR implants.
        in: Presented at the 12th World Congress on Fertility and Sterility, SingaporeOctober, 1986
      1. Zegers-Hochschild, F., Massai, R., Altieri, E., Pacheco, I. and Hall, P. Follicular growth and development during continuous treatment with a low dose of levonorgestrel delivered by vaginal rings. Contraception, submitted.